NEW YORK (360Dx) – Biopharma firm iBio said today it has partnered with TheoremDx to develop proteins for use in rapid diagnostic testing of tropical diseases.

Under the collaboration, iBio will develop and produce proteins that TheoremDx will use with its point-of-care testing platform to diagnose diseases including the Zika, Dengue, Chikungunya, and West Nile viruses and to develop an improved HIV test.